Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T21:12:00.581Z Has data issue: false hasContentIssue false

Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis

Published online by Cambridge University Press:  02 January 2018

M.-P. V. Austin
Affiliation:
Edinburgh University Department of Psychiatry, Royal Edinburgh Hospital
F. G. M. Souza
Affiliation:
Edinburgh University Department of Psychiatry, and Assistant Professor, State University of Ceara, Messejana Mental Health Hospital, Fortaleza, Brazil
G. M. Goodwin*
Affiliation:
MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF
*
∗ Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

A quantitative analysis was used to examine the efficacy of lithium augmentation in the acute treatment of depressed patients resistant to a standard trial of an antidepressant. Effect sizes were measured by the odds ratio using the Mantel–Haenszel method. Only controlled trials were included in order to minimise bias in method. A highly statistically significant effect for lithium augmentation was found, the pooled odds ratio being 0.146 and its 95% confidence interval 0.05–0.44 (i.e. the odds of remaining ill are reduced by between 56% and 95% with the use of lithium treatment). While these results support the case for lithium augmentation in treatment-resistant depression, there remains considerable uncertainty over the duration of treatment necessary to see and sustain the treatment response.

Information

Type
Papers
Copyright
Copyright © 1991 The Royal College of Psychiatrists 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.